Sign up for our free daily newsletters here! Note: subscribers can access our search feature!
Welcome to Hospice & Palliative Care Today, a daily email summarizing numerous topics essential for understanding the current landscape of serious illness and end-of-life care. Teleios Collaborative Network podcasts review Hospice & Palliative Care Today monthly content - click here for these and all TCN Talks podcasts.
Saturday newsletters focus on headlines and research - enjoy!
Changes in RI hospice utilization and quality of care with increase in number of hospice programs
Journal of Pain and Symptom Management; by Joan Teno; 3/26
The number of licensed hospice programs in Rhode Island increased from four prior to 2017 to eleven by 2025, with many new providers being for-profit entities, some backed by private equity. Using public data, I analyzed trends in hospice use and quality, hypothesizing that the growth in providers may increase health care costs and raise concerns about the quality of care. Using public data, I analyzed trends in hospice use and quality, hypothesizing that the growth in providers may increase health care costs and raise concerns about the quality of care... Compared to not-for-profit hospices, for-profit providers showed significant differences in several measures, including a higher focus on enrolling patients with dementia—a population that may be more profitable because of their long length of stay and higher live discharge rates. A four-point difference in bereaved caregiver willingness to recommend for profit hospices indicates a moderate effect size and raises concerns about quality.
State POLST program maturity status and dying in the nursing home or hospice in the United States: An event time study
Journal of the American Medical Directors Association; by Komal Patel Murali, May Hua, Patricia W Stone, Andrew Dick, Tadeja Gracner; 2/26
State Physician Orders for Life-Sustaining Treatment (POLST) programs ensure documentation of orders for treatment are documented for the provision of goal-concordant care at the end of life. The national POLST organization tracks the maturity stages of state programs and categorizes them as developed (beginning of use) and endorsed (benchmarks and standardized use). Examining the association between POLST program maturation and the likelihood of dying in place can help clarify how implementation stage may affect end-of-life care and place of death. POLST program maturity is associated with a higher likelihood of NH residents dying in place or in hospice, potentially supporting goal-concordant care and reducing burdensome hospital transfers near the end of life.
![]() |
![]() |
Nursing home profit status and pain among residents living with dementia
Pain Management Nursing; by Sorah Levy, Barbara Resnick, Elizabeth Galik, Kelly Doran, Tara McMullen, Sarah Holmes; 2/26
Nursing home (NH) residents living with dementia experience pain that is often sub-optimally managed. Nearly one in five nursing home residents with dementia experience pain symptoms.There is a known relationship between NH organizational factors, such as profit status, and quality of care. However, little attention has been paid to understanding the relationship between NH ownership profit status and pain among residents living with dementia. NH ownership profit status was not significantly associated with pain ...
![]() |
Characteristics of United States Food and Drug Administration drug recalls involving opioid medications, 2002-2025
Pharmacoepidemiology and Drug Safety; by Julio C Nunes, Gabriel P A Costa, Joao P De Aquino; 3/26
We reviewed more than 20 years of recall data from the United States Food and Drug Administration and found 286 recalls involving seven commonly used opioids, affecting over 350 million tablets, capsules, patches, and injectable products. Nearly half of these recalls occurred because products failed basic quality checks, while others involved incorrect doses, contamination, mislabeling, or defective delivery systems. The most serious recalls, those carrying risk of serious injury or death, were concentrated among fentanyl, morphine, and hydromorphone. Many recall notices lacked important details, including the number of units affected, making it difficult to understand how these issues may impact patients. Our findings show that opioid recalls happen regularly and often reflect manufacturing problems that could influence treatment safety or effectiveness.
![]() |
Feasibility and acceptability of a self-written, tele-delivered, LGBTQ+-affirming adaptation of dignity therapy for LGBTQ+ women with advanced cancer
American Journal of Hospice & Palliative Medicine; by Lexie Wille, Kristie A. Wood, Mike C. Parent; 2/26
Dignity therapy (DT) is effective in addressing dignity-related existential distress in people with advanced cancer, but the traditional protocol assumes supportive family structures, uses heteronormative language, and requires synchronous clinician facilitation. These features may limit accessibility for LGBTQ+ individuals. This pilot demonstrated that a self-written, tele-delivered LGBTQ+-affirming DT adaptation was feasible and acceptable for LGBTQ+ women with advanced cancer.
![]() |
![]() |
The Fine Print:
Paywalls: Some links may take readers to articles that either require registration or are behind a paywall. Disclaimer: Hospice & Palliative Care Today provides brief summaries of news stories of interest to hospice, palliative, and end-of-life care professionals (typically taken directly from the source article). Hospice & Palliative Care Today is not responsible or liable for the validity or reliability of information in these articles and directs the reader to authors of the source articles for questions or comments. Additionally, Dr. Cordt Kassner, Publisher, and Dr. Joy Berger, Editor in Chief, welcome your feedback regarding content of Hospice & Palliative Care Today. Unsubscribe: Hospice & Palliative Care Today is a free subscription email. If you believe you have received this email in error, or if you no longer wish to receive Hospice & Palliative Care Today, please unsubscribe here or reply to this email with the message “Unsubscribe”. Thank you.


